HONG KONG, Aug. 9, 2024 /PRNewswire/ — QMMM Holdings Limited (Nasdaq: QMMM) (the “Company” or “QMMM Holdings”), a digital media advertising, virtual avatar & virtual apparel technology service provider in Hong Kong, today announced that WallachBeth Capital, LLC, as representative of the underwriters of the Company’s firm commitment initial public offering (“IPO”), has partially exercised […]
Category Archives: Pr Newswire
HANGZHOU, China, Aug. 8, 2024 /PRNewswire/ — In the sweltering summer, affected by the continuous hot and dry weather with little rain, farmland irrigation is facing considerable pressure. On August 8th, staff members from State Grid Hangzhou Power Supply Company came to the fields in Baisuifang Village, Tonglu County, carefully inspected agricultural power supply facilities to […]
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ — EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy life for all. EmeTerm® Smart is launching on Indiegogo as the world’s first anti-nausea smart watch. EmeTerm® Smart’s story is one of heartfelt […]
Ahead of the 59th National Day celebrations, McCann Worldgroup Singapore’s research reveals attitudes on life and work in the Little Red Dot. SINGAPORE, Aug. 8, 2024 /PRNewswire/ — Data in McCann Worldgroup Singapore’s Truth Study, The Truth about Singapore, explores the profound shifts that are taking place in work and culture in the city state. And whilst there is much for Singapore […]
NEW YORK, Aug. 8, 2024 /PRNewswire/ — LILYSILK, the world’s leading silk brand with a mission to inspire people to live spectacular, sustainable lives, proudly celebrates its 14th anniversary themed “From Bud to Bloom: LILYSILK’s Sustainable Evolution“. This milestone marks a significant evolution towards sustainability, reflecting the brand’s ongoing commitment to elegance, quality, and environmental […]
Pr Newswire
Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference
08
Aug
Aug
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference on Tuesday, […]
Pr Newswire
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08
Aug
Aug
Over 122,000 prescriptions for VOQUEZNA® products written by healthcare providers, launch to date, a 184% increase since last quarterly report Net revenues of $7.3 million reported for the second quarter 2024 compared to $1.9 million in the first quarter 2024, greater than a 280% increase VOQUEZNA (vonoprazan) tablets 10mg now FDA-approved and available to treat […]
Pr Newswire
Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September
08
Aug
Aug
COPENHAGEN, Denmark, Aug. 08, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, is proud to announce the presentation of one-year clinical efficacy Phase 2 data for its lead compound EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2024, taking place in […]
08
Aug
Aug
FARMINGTON HILLS, Mich., Aug. 08, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced that George Magrath, M.D., M.B.A., M.S., Chief Executive Officer, will present at the Canaccord Genuity 44th […]
08
Aug
Aug
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that Dr. Nathan Mata, Chief Scientific Officer of Belite Bio, will present a corporate update at the H.C. Wainwright […]